检索结果 - Frank Vari

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma

    Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma 由 Kimberley Jones, Frank Vari, Colm Keane, Pauline Crooks, Jamie P. Nourse, Louise Seymour, David Gottlieb, David Ritchie, Devinder Gill, Maher K. Gandhi

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

    EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2 由 Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West, Muhammed B. Sabdia, Soi Cheng Law, Jay Gunawardana, Frank Vari, Sally Mujaj, Gayathri Thillaiyampalam, Cameron Snell, Madeline Gough, Colm Keane, Maher K. Gandhi

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL

    Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL 由 Frank Vari, David Arpon, Colm Keane, Mark Hertzberg, Dipti Talaulikar, Sanjiv Jain, Qingyan Cui, Erica Han, Joshua W.D. Tobin, Robert Bird, Donna Cross, Annette Hernandez, Clare Gould, Simone Birch, Maher K. Gandhi

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma

    The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma 由 Kimberley Jones, Leesa Wockner, R.M. Brennan, Colm Keane, Pratip K. Chattopadhyay, Mario Roederer, David A. Price, David K. Cole, Brekhna Hassan, Konrad Beck, David Gottlieb, David Ritchie, John F. Seymour, Frank Vari, Pauline Crooks, Scott R. Burrows, Maher K. Gandhi

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma

    The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma 由 Colm Keane, Clare Gould, Kimberley Jones, David Hamm, Dipti Talaulikar, Jonathan Ellis, Frank Vari, Simone Birch, Erica Han, Peter Wood, Kim‐Anh Lê Cao, Michael R. Green, Pauline Crooks, Sanjiv Jain, Joshua W.D. Tobin, Raymond J. Steptoe, Maher K. Gandhi

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

    Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration 由 Joshua W.D. Tobin, Colm Keane, Jay Gunawardana, Peter Mollee, Simone Birch, Thanh Hoang, Justina Lee, Li Li, Li Huang, Valentine Murigneux, J. Lynn Fink, Nicholas Matigian, Frank Vari, Santiyagu M. Savarimuthu Francis, Robert Kridel, Oliver Weigert, Sarah Haebe, Vindi Jurinović, Wolfram Klapper, Christian Steidl, Laurie H. Sehn, Soi Cheng Law, Michelle Wykes, Maher K. Gandhi

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

    EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity 由 Maher K. Gandhi, Thanh Hoang, Soi Cheng Law, Sandra Brosda, Kacey O’Rourke, Joshua W.D. Tobin, Frank Vari, Valentine Murigneux, J. Lynn Fink, Jay Gunawardana, Clare Gould, Harald Oey, Karolina Bednarska, Susanne Delécluse, Ralf Ulrich Trappe, Lilia Merida de Long, Muhammed B. Sabdia, Govind Bhagat, Greg Hapgood, Emily Blyth, Luke Clancy, Joel Wight, Eliza A. Hawkes, Lisa M. Rimsza, Alanna Maguire, Kamil Bojarczuk, Bjoern Chapuy, Colm Keane

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

    CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells 由 Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, Dillon Corvino, Kimberley Stannard, Sophie Krumeich, Indrajit Das, Luize Goncalves Lima, Lizeth G. Meza Guzman, Kunlun Li, Rui Li, Nazhifah Salim, Maria Villancanas Jorge, Sunyoung Ham, Gabrielle Kelly, Frank Vari, Ailin Lepletier, Ashwini Raghavendra, Sally‐Ann Pearson, Jason Madore, Sébastien Jacquelin, Maike Effern, Brodie Quine, Lambros T. Koufariotis, Mika Casey, Kyohei Nakamura, Eun Young Seo, Michael Hölzel, Matthias Geyer, Glen Kristiansen, Touraj Taheri, Elizabeth Ahern, Brett Hughes, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Martin Batstone, Jennifer Landsberg, Dimo Dietrich, Oltin T. Pop, Lukas Flatz, William C. Dougall, André Veillette, Sandra E. Nicholson, Andreas Möller, Robert J. Johnston, Ludovic Martinet, Mark J. Smyth, Tobias Bald

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: